Posts Tagged ‘non-small cell lung cancer’

Expanding Lung Cancer Treatment Options with Proton Therapy

proton therapy lung cancer awarenessThe National Cancer Institute predicts an estimated 228,150 new cases of lung cancer will be diagnosed in 2019, accounting for 12.9% of all new cancer cases for the year. Lung cancer is identified as two main types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

Non-small cell lung cancer is the most common form of lung cancer and accounts for 85% of lung cancer cases. Small cell lung cancer accounts for 10% to 15% of cases and generally grows more quickly, and is likely to spread to other parts of the body.

Proton Therapy, Power and Precision

Proton therapy has ushered in a new form of treatment for specific patients with lung cancer.

Many patients with lung cancer receive radiation treatment for early-stage disease. A highly focused type of radiation called stereotactic body radiation therapy can provide excellent outcomes. Proton therapy may be an appropriate option for some patients, often those with Stage III lung cancer or who need radiation after surgery.

Proton therapy can reduce or avoid radiation to the healthy, normal lung tissues and esophagus in certain cases. This may reduce the risks of swallowing difficulty or heart and lung problems after treatment.

Patients may also be eligible to participate in an ongoing national clinical trial comparing X-ray-based radiation and proton therapy to determine if proton therapy may improve outcomes or reduce risks of treatment.

Emory Proton Therapy Center

The experienced physicians and specialists from Winship Cancer Institute of Emory University and Emory Proton Therapy Center will work closely with you or a loved one to develop the most effective treatment plan with the fewest potential side effects. To learn more about proton therapy and the Emory Proton Therapy Center, visit winshipcancer.emory.edu/proton.

Cancer patients needing consultation, or their caregivers or physicians, can schedule a consultation by calling 1-833-3PROTON (1-833-377-6866) where an Emory Proton Therapy Center professional will promptly respond, or by filling out a consultation web form.

Request an appointment

 

Join Us for a Live Web Chat: Lung Cancer

Lung cancer is the deadliest form of cancer among both men and women. It’s responsible for more deaths each year than breast, colon, and prostate cancers combined. Older adults are at a greater risk for lung cancer; it’s less common in adults under the age of 45. There are several other factors that can increase a person’s risk for lung cancer, but evidence undeniably shows that smokers are at the greatest risk. Studies show the earlier a person starts smoking and the more cigarettes smoked on a per-day basis, the greater the risk for lung cancer.

To learn more about other risk factors for lung cancer, and to get information including screening recommendations, lung cancer prevention tips, and information on survivorship resources, join us for an online chat!

On November 27 at noon (ET) we’re hosting a free online web chat with lung cancer expert Dr. Suresh Ramalingam, MD, Associate Professor, Hematology & Medical Oncology from Winship Cancer Institute of Emory University, Georgia’s only National Cancer Institute-designated cancer center.

Chat Transcript HERE